Another study by Miller et al. [22] demonstrated that DLBCL patients with a high Ki-67 (≥ 80%) had a significantly worse outcome compared to those with a low Ki-67 (<80%). This evidence concerns the gene MKI67 and diffuse large B-cell lymphoma.